Article Details
Retrieved on: 2025-02-11 14:55:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anthos is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI ...
Article found on: www.contractpharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here